|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.00 INR | +0.71% |
|
+1.34% | -34.96% |
| Market Cap | 98Cr 1.02Cr 88.87L 82.71L 75.94L 1.43Cr 1.46Cr 9.75Cr 3.83Cr 49Cr 3.84Cr 3.75Cr 162.91Cr | P/E 2024 |
-14.8x | P/E 2025 | -22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 134.42Cr 1.41Cr 1.22Cr 1.14Cr 1.05Cr 1.98Cr 2.01Cr 13Cr 5.27Cr 67Cr 5.29Cr 5.17Cr 224.39Cr | EV / Sales 2024 |
1,23,82,225x | EV / Sales 2025 | 1,42,98,457x |
| Free-Float |
25.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.71% | ||
| 1 week | +1.34% | ||
| 1 month | -20.45% | ||
| 3 months | +4.48% | ||
| 6 months | -25.36% | ||
| Current year | -34.96% |
| 1 week | 29.5 |  | 31.9 |
| 1 month | 29.12 | | 38.49 |
| Current year | 25.6 | | 50.9 |
| 1 year | 25.6 | | 68 |
| 3 years | 25.6 | | 87.46 |
| 5 years | 10.17 | | 87.46 |
| 10 years | 2.15 | | 87.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 13/10/2022 | |
| Chief Tech/Sci/R&D Officer | - | 07/08/2025 | |
| Compliance Officer | - | 14/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Mini Manikantan
BRD | Director/Board Member | - | 09/07/2022 |
| Director/Board Member | - | - | |
| Chairman | 75 | 05/12/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.71% | +1.34% | -50.65% | -22.67% | 1.15Cr | |
| -0.53% | -3.95% | +55.23% | +152.74% | 1,02400Cr | |
| +0.21% | -2.68% | +55.61% | +53.02% | 62TCr | |
| -2.51% | -3.25% | +32.76% | +67.76% | 44TCr | |
| +0.06% | -0.42% | +37.53% | +30.67% | 35TCr | |
| -0.14% | -0.24% | +34.41% | +39.01% | 30TCr | |
| -0.69% | -0.30% | +11.55% | +12.93% | 26TCr | |
| -7.37% | -4.40% | -2.54% | -43.87% | 21TCr | |
| -0.64% | +2.43% | +30.52% | +64.49% | 21TCr | |
| -0.82% | +0.70% | +15.96% | +71.01% | 16TCr | |
| Average | -1.17% | -0.94% | +22.04% | +42.51% | 35.74TCr | |
| Weighted average by Cap. | -0.99% | -1.93% | +39.24% | +72.95% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 151.12 1.58 1.38 1.28 1.18 2.22 2.26 15.1 5.93 75.23 5.95 5.81 252.27 | 195.14 2.04 1.78 1.65 1.52 2.87 2.91 19.5 7.65 97.15 7.68 7.51 325.75 |
| Net income | -7.97Cr -8L -7L -7L -6L -11.71L -11.89L -79.61L -31.24L -3.97Cr -31.35L -30.66L -13Cr | -11Cr -11.29L -10L -9L -8L -15.84L -16.08L -1.08Cr -42.26L -5.37Cr -42.4L -41.47L -18Cr |
| Net Debt | 3.73Cr 4L 3L 3L 3L 5L 6L 37.25L 14.62L 1.86Cr 14.67L 14.35L 6.22Cr | 37Cr 38.58L 33.54L 31.22L 28.66L 54.13L 54.96L 3.68Cr 1.44Cr 18Cr 1.45Cr 1.42Cr 61Cr |
Employees
28
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | ₹31.00 | +0.71% | 1,876 |
| 30/26/30 | ₹30.78 | +1.58% | 3,591 |
| 29/26/29 | ₹30.30 | +0.93% | 2,208 |
| 28/26/28 | ₹30.02 | -1.54% | 1,580 |
| 27/26/27 | ₹30.49 | -0.33% | 3,720 |
- Stock Market
- Stocks
- PHARMAID Stock
Select your edition
All financial news and data tailored to specific country editions
